UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Genetic Variant of DNAM-1 rs763361 C>T Is Associated with Ankylosing Spondylitis in a Mexican Population

Current issues in molecular biology, 2024-03, Vol.46 (4), p.2819-2826

2024

Volltextzugriff (PDF)

Control of Metastasis by NK Cells

Cancer cell, 2017-08, Vol.32 (2), p.135-154

2017

Volltextzugriff (PDF)

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer

Oncoimmunology, 2020-01, Vol.9 (1), p.1843247-1843247

2020

Volltextzugriff (PDF)

Cataloging circulating CD3+CD56+ NKT-like cells through a series of stimulating (NKG2D and DNAM-1) and inhibitory (PD-1, TIGIT, and Tim-3) immune checkpoint receptors in women diagnosed with precancerous cervical lesions or invasive cervical carcinoma

Immunology letters, 2024-10, Vol.269, p.106889, Article 106889

2024

Volltextzugriff (PDF)

Structural basis for the immune recognition and selectivity of the immune receptor PVRIG for ligand Nectin-2

Structure (London), 2024-07, Vol.32 (7), p.918-929.e4

2024

Volltextzugriff (PDF)

Recognition of Tumors by the Innate Immune System and Natural Killer Cells

Advances in Immunology, 2014, Vol.122, p.91-128

2014

Volltextzugriff (PDF)

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

Immunity (Cambridge, Mass.), 2020-10, Vol.53 (4), p.805-823.e15

2020

Volltextzugriff (PDF)

Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death

Cell, 2024-02, Vol.187 (3), p.624-641.e23

2024

Volltextzugriff (PDF)

Senescent cells: Living or dying is a matter of NK cells

Journal of leukocyte biology, 2019-06, Vol.105 (6), p.1275-1283, Article 1275

2019

Volltextzugriff (PDF)

DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy

Cancers, 2019-06, Vol.11 (6), p.877

2019

Volltextzugriff (PDF)

Targeting novel inhibitory receptors in cancer immunotherapy

Seminars in immunology, 2020-06, Vol.49, p.101436-101436, Article 101436

2020

Volltextzugriff (PDF)

Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation

Proceedings of the National Academy of Sciences - PNAS, 2016-05, Vol.113 (21), p.E2973-E2982

2016

Volltextzugriff (PDF)

Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands

Oncoimmunology, 2022-12, Vol.11 (1), p.2138152-2138152

2022

Volltextzugriff (PDF)

DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions

Proceedings of the National Academy of Sciences - PNAS, 2021-05, Vol.118 (21), p.1

2021

Volltextzugriff (PDF)

Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis

Immunologic research, 2024-05

2024

Volltextzugriff (PDF)

Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment

Cancers, 2023-09, Vol.15 (18), p.4616

2023

Volltextzugriff (PDF)

NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia

Journal of leukocyte biology, 2024-01, Vol.115 (2), p.334-343

2024

Volltextzugriff (PDF)

Critical roles of co‐activation receptor DNAX accessory molecule‐1 in natural killer cell immunity

Immunology, 2015-11, Vol.146 (3), p.369-378

2015

Volltextzugriff (PDF)

The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells

Frontiers in immunology, 2014-01, Vol.4, p.508-508

2014

Volltextzugriff (PDF)

Dendritic cell derived cytokines in human natural killer cell differentiation and activation

Frontiers in immunology, 2013, Vol.4, p.365-365

2013

Volltextzugriff (PDF)

NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection

Frontiers in immunology, 2016-08, Vol.7, p.323-323

2016

Volltextzugriff (PDF)

Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes

Immunity (Cambridge, Mass.), 2020-01, Vol.52 (1), p.96-108.e9

2020

Volltextzugriff (PDF)

IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo

Oncoimmunology, 2017-01, Vol.6 (3), p.e1274478-e1274478

2017

Volltextzugriff (PDF)

Concomitant deletion of SLAM‐family receptors, NKG2D and DNAM‐1 reveals gene redundancy of NK cell activating receptors in NK cell development and education

Journal of leukocyte biology, 2020-04, Vol.107 (4), p.561-572

2020

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(99)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Dnam-1
(85)
Life Sciences & Biomedicine
(82)
Immunology
(54)
Humans
(51)
Oncology
(32)
Killer Cells, Natural - Immunology
(29)
Ligands
(28)
Nkg2d
(28)
Natural Killer Cells
(26)
Nk Cells
(25)
Cytotoxicity
(23)
Lymphocytes
(22)
Animals
(21)
Antigens, Differentiation, T-Lymphocyte - Immunology
(21)
Cancer
(20)
Cd226 Antigen
(18)
Tigit
(18)
Immunotherapy
(15)
Female
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Genetic Variant of DNAM-1 rs763361 C>T Is Associated with Ankylosing Spondylitis in a Mexican Population

Control of Metastasis by NK Cells

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer

Cataloging circulating CD3+CD56+ NKT-like cells through a series of stimulating (NKG2D and DNAM-1) and inhibitory (PD-1, TIGIT, and Tim-3) immune checkpoint receptors in women diagnosed with precancerous cervical lesions or invasive cervical carcinoma

Structural basis for the immune recognition and selectivity of the immune receptor PVRIG for ligand Nectin-2

Recognition of Tumors by the Innate Immune System and Natural Killer Cells

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death

Senescent cells: Living or dying is a matter of NK cells

DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy

Targeting novel inhibitory receptors in cancer immunotherapy

Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation

Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands

DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions

Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis

Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy

NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia

Critical roles of co‐activation receptor DNAX accessory molecule‐1 in natural killer cell immunity

The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells

Dendritic cell derived cytokines in human natural killer cell differentiation and activation

NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection

Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes

IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo

Concomitant deletion of SLAM‐family receptors, NKG2D and DNAM‐1 reveals gene redundancy of NK cell activating receptors in NK cell development and education

Suchergebnisse filtern